SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📊Dashboards🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
therapeutic 1,175 words KG: GSK3
Contents

GSK3 Inhibitor Therapy

💊 Therapeutic Info
NameGSK3
Key Genes/ProteinsABL1, ACAT1, ACETYL-COA, Actin, AGING, AIF
Related DiseasesAging, Als, ALS, Alzheimer, Alzheimer's disease
Related PathwaysAkt
Linked Hypotheses2 hypotheses

No AI portrait yet

Knowledge Graph

Related Hypotheses (52)

Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.73Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71HDAC3-Selective Inhibition for Clock Reset
Score: 0.71Orexin-Microglia Modulation Therapy
Score: 0.71TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70Lysosomal Calcium Channel Modulation Therapy
Score: 0.70Complement C1q Mimetic Decoy Therapy
Score: 0.69Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.69Ganglioside Rebalancing Therapy
Score: 0.69Hypocretin-Neurogenesis Coupling Therapy
Score: 0.69TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69R-Loop Resolution Enhancement Therapy
Score: 0.68Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.67Arginine Methylation Enhancement Therapy
Score: 0.65Glial Glycocalyx Remodeling Therapy
Score: 0.65HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.65Serine/Arginine-Rich Protein Kinase Modulation
Score: 0.62Vagal Afferent Microbial Signal Modulation
Score: 0.62
← Prevpg 2/3Next →

Related Analyses (24)

Synaptic pruning by microglia in early AD
neurodegeneration · completedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completedCircuit-level neural dynamics in neurodegeneration
neuroscience · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archivedAstrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Related Experiments (7)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90P2RY12-MTOR pathway interaction in VSMCs
exploratory · proposed · Score: 0.85iPSC-NPC transplantation in ICH animal model
validation · proposed · Score: 0.85Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40

See Also (13)

AMPK (AMP-Activated Protein Kinase)
entity · KG edge: activatesAlzheimer Indonesia
institution · KG edge: activatesAging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: activatesLX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy
clinical · Pages share 4 hypothesesLX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 4 hypotheses

Knowledge Graph (12 edges)

GSK3 interacts_with MTOR
CDK5 associated_with GSK3
GSK3 associated_with MARK4
GSK3 associated_with Alzheimer's disease
AKT activates GSK3
MTOR activates GSK3
PI3K activates GSK3
AMPK activates GSK3
BECN1 activates GSK3
LC3 activates GSK3

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

SciDEX — scidex.ai — Dashboard | Atlas